Publications by authors named "Jan Taprogge"

Claim this Profile
A
A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid Cancer.
Jan Taprogge, Iain Murray, Kate Newbold, Kate Garcez, Jonathan Wadsley

Thyroid· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.
Jan Taprogge, Iain Murray, Hannah Sharman, Paul Gape, Francesca Leek

Eur Thyroid J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validation protocol forLu-SPECT image quantification as a basis for multi-centre kidney dosimetry.
Lovisa Jessen, Selma Curkic Kapidzic, Johan Gustafsson, Erik Larsson, Michael Ljungberg, Jan Taprogge

Phys Med Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the reduction of imaging time-points for dosimetry in radionuclide therapy.
Johan Gustafsson, Jan Taprogge

EJNMMI Phys· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future trends for patient-specific dosimetry methodology in molecular radiotherapy.
Johan Gustafsson, Jan Taprogge

Phys Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project.
Jan Taprogge, Alex Vergara-Gil, Francesca Leek, Carla Abreu, Lenka Vávrová

Eur J Nucl Med Mol Imaging· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
Jon Wadsley, Gemma Ainsworth, Amy Beth Coulson, Kate Garcez, Laura Moss, Jan Taprogge

Thyroid· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer.
Jan Taprogge, Carla Abreu, Siraj Yusuf, Gemma Ainsworth, Rachel H Phillip

J Nucl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial results of the INSPIRE clinical trial-investigating radiation dosimetry for differentiated thyroid cancer patients.
Jan Taprogge, Carla Abreu, Lenka Vávrová, Lily Carnegie-Peake, Dominic Rushforth

Front Nucl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation protection aspects for alpha therapies.
Allison J Craig, Jan Taprogge, Glenn D Flux, Iain Murray

Q J Nucl Med Mol Imaging· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification and dosimetry of small volumes including associated uncertainty estimation.
Lily Carnegie-Peake, Jan Taprogge, Iain Murray, Glenn D Flux, Jonathan Gear

EJNMMI Phys· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy.
Glenn Flux, Francesca Leek, Paul Gape, Jonathan Gear, Jan Taprogge

Semin Nucl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy.
Johan Gustafsson, Jan Taprogge

Phys Med Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease.
Jan Taprogge, Paul M D Gape, Lily Carnegie-Peake, Iain Murray, Jonathan I Gear

Thyroid· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjustment of the iodine ICRP population pharmacokinetic model for the use in thyroid cancer patients after thyroidectomy.
Jan Taprogge, Lily Carnegie-Peake, Iain Murray, Jonathan I Gear, Glenn D Flux

J Radiol Prot· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project.
Jan Taprogge, Francesca Leek, Tino Schurrat, Johannes Tran-Gia, Delphine Vallot

EJNMMI Phys· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compartmental Model for Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.
Jan Taprogge, Iain Murray, Jonathan Gear, Sarah J Chittenden, Christopher C Parker

Int J Radiat Oncol Biol Phys· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer.
Jan Taprogge, Francesca Leek, Glenn D Flux

Q J Nucl Med Mol Imaging· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimation.
Jonathan I Gear, Jan Taprogge, Owen White, Glenn D Flux

EJNMMI Phys· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis